Advertisement

Table of Contents

April 01, 1991; Volume 39,Issue 4

You have access
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
S P Berger, R E Martenson, P Laing, A Thurkauf, B Decosta, K C Rice and S M Paul

Molecular Pharmacology April 1991, 39 (4) 429-435;
You have access
Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb.
P Onali and M C Olianas

Molecular Pharmacology April 1991, 39 (4) 436-441;
You have access
Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression.
C Rius, A R Zorrilla, C Cabañas, F Mata, C Bernabeu and P Aller

Molecular Pharmacology April 1991, 39 (4) 442-448;
You have access
Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
P Huang and W Plunkett

Molecular Pharmacology April 1991, 39 (4) 449-455;
You have access
Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs.
Y Kanazawa, M Kitada, T Mori, Y Inukai, S Imaoka, Y Funae and T Kamataki

Molecular Pharmacology April 1991, 39 (4) 456-460;
You have access
Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance.
T H Manoharan, P J Welch, A M Gulick, R B Puchalski, A L Lathrop and W E Fahl

Molecular Pharmacology April 1991, 39 (4) 461-467;
You have access
Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone.
K Wright and E T Morgan

Molecular Pharmacology April 1991, 39 (4) 468-474;
You have access
Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
S Nakashima, T Koike and Y Nozawa

Molecular Pharmacology April 1991, 39 (4) 475-480;
You have access
Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtype.
A L Wilson, K Seibert, S Brandon, E J Cragoe and L E Limbird

Molecular Pharmacology April 1991, 39 (4) 481-486;
You have access
Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function.
P M Vertino, T A Beerman, E J Kelly, R J Bergeron and C W Porter

Molecular Pharmacology April 1991, 39 (4) 487-494;
You have access
2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression.
G C Clark, J A Blank, D R Germolec and M I Luster

Molecular Pharmacology April 1991, 39 (4) 495-501;
You have access
Theoretical study of the flexibility and solution conformation of the cyclic opioid peptides [D-Pen2,D-Pen5]enkephalin and [D-Pen2,L-Pen5]enkephalin.
C Chew, H O Villar and G H Loew

Molecular Pharmacology April 1991, 39 (4) 502-510;
You have access
Directed shift of fatty acids from phospholipids to triacylglycerols in HL-60 cells induced by nanomolar concentrations of triethyl lead chloride: involvement of a pertussis toxin-sensitive pathway.
H F Krug and H Culig

Molecular Pharmacology April 1991, 39 (4) 511-516;
You have access
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling.
M J Lohse, K N Klotz and U Schwabe

Molecular Pharmacology April 1991, 39 (4) 517-523;
You have access
Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction.
W Gross and M J Lohse

Molecular Pharmacology April 1991, 39 (4) 524-530;
You have access
Regulation of dopamine D2 receptors in a novel cell line (SUP1).
K J Ivins, R R Luedtke, R P Artymyshyn and P B Molinoff

Molecular Pharmacology April 1991, 39 (4) 531-539;
You have access
Actions of cardiac drugs on a calcium-dependent potassium channel in hippocampal neurons.
J G McLarnon and X P Wang

Molecular Pharmacology April 1991, 39 (4) 540-546;
You have access
Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
M H Werner, L Senzel, A Bielawska, W Khan and Y A Hannun

Molecular Pharmacology April 1991, 39 (4) 547-556;
You have access
Alpha-difluoromethylornithine inhibits bone resorption in vitro without decreasing beta-glucuronidase release.
P H Stern, R C Lucas and J Seidenfeld

Molecular Pharmacology April 1991, 39 (4) 557-562;
You have access
In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
Z Y Dong, N E Ward, D Fan, K P Gupta and C A O'Brian

Molecular Pharmacology April 1991, 39 (4) 563-569;
You have access
Regulation of dopamine D2 receptors by sodium and pH.
K A Neve

Molecular Pharmacology April 1991, 39 (4) 570-578;
You have access
DuP 753 can antagonize the effects of angiotensin II in rat liver.
P H Bauer, A T Chiu and J C Garrison

Molecular Pharmacology April 1991, 39 (4) 579-585;